Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

GPCR SIGNALING

Leveraging bias to your advantage

Characterization of biased receptor signaling has ushered in opportunities for unprecedented control of G-protein-coupled receptors. Elucidation of distinct M1 muscarinic acetylcholine receptor signaling pathways and development of biased ligands may offer novel and safer Alzheimer’s disease therapeutics.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Purchase on Springer Link

Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Probing the signaling pathway(s) that mediate the effects of M1 mAChR modulation.

References

  1. Moran, S. P., Maksymetz, J. & Conn, P. J. Trends Pharmacol. Sci. 40, 1006–1020 (2019).

    Article  CAS  Google Scholar 

  2. Bradley, S. J. et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-019-0453-9 (2020).

  3. Bender, A. M., Jones, C. K. & Lindsley, C. W. ACS Chem. Neurosci. 8, 435–443 (2017).

    Article  CAS  Google Scholar 

  4. Voss, T. et al. Alzheimers Dement. (N. Y.) 4, 173–181 (2018).

    Google Scholar 

  5. Sako, Y. et al. Neuropsychopharmacology 44, 950–960 (2019).

    Article  CAS  Google Scholar 

  6. Kurimoto, E. et al. J. Pharmacol. Exp. Ther. 364, 28–37 (2018).

    Article  CAS  Google Scholar 

  7. Marlo, J. E. et al. Mol. Pharmacol. 75, 577–588 (2009).

    Article  CAS  Google Scholar 

  8. Moran, S. P. et al. Sci. Signal. 12, eaax2057 (2019).

    Article  CAS  Google Scholar 

  9. Moran, S. P. et al. Neuropsychopharmacology 43, 1763–1771 (2018).

    Article  CAS  Google Scholar 

  10. Moran, S. P. et al. ACS Chem. Neurosci. 9, 2218–2224 (2018).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Jeffrey Conn.

Ethics declarations

Competing interests

The authors declare no competing interests

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moran, S.P., Conn, P.J. Leveraging bias to your advantage. Nat Chem Biol 16, 226–227 (2020). https://doi.org/10.1038/s41589-020-0468-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41589-020-0468-2

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing